Genentech
Genentech, Inc.
1 DNA Way,
South San Francisco,
CA 94080
Phone: (650) 225-1000Website: https://www.gene.com/Careers: www.gene.com/careers
Latest news
- FDA Approves PiaSky (crovalimab-akkz) for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
24 June 2024 - First Patient Dosed in Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer
15 May 2024 - FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
18 April 2024 - Antibody Reduces Allergic Reactions to Multiple Foods in NIH Clinical Trial
25 February 2024 - FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies
16 February 2024 - FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
26 October 2023 - FDA Expands Pediatric Indication for Rozlytrek (entrectinib) and Approves New Pellet Formulation
20 October 2023 - FDA Accepts Application for Genentech’s Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition
4 September 2023 - FDA Grants Regular Approval for Gavreto (pralsetinib) for Non-Small Cell Lung Cancer with RET Gene Fusions
9 August 2023 - Genprex Receives Fast Track Designation for REQORSA Immunogene Therapy in Combination with Tecentriq for the Treatment of Small Cell Lung Cancer
28 June 2023
Drugs Associated with Genentech, Inc.
Genentech, Inc. manufactures, markets and/or distributes more than 43 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Actemra
Generic name: tocilizumab Drug class: interleukin inhibitors |
42 reviews | 6.9 / 10 |
Activase
Generic name: alteplase Drug class: thrombolytics |
1 review | 10 / 10 |
Alecensa
Generic name: alectinib Drug class: multikinase inhibitors |
2 reviews | 9.5 / 10 |
Avastin
Generic name: bevacizumab Drug class: VEGF/VEGFR inhibitors |
26 reviews | 7.7 / 10 |
Cathflo Activase
Generic name: alteplase Drug class: thrombolytics |
1 review | 10 / 10 |
CellCept
Generic name: mycophenolate mofetil Drug class: selective immunosuppressants |
33 reviews | 8.3 / 10 |
Cotellic
Generic name: cobimetinib Drug class: multikinase inhibitors |
||
Enspryng
Generic name: satralizumab Drug class: interleukin inhibitors |
||
Erivedge
Generic name: vismodegib Drug class: hedgehog pathway inhibitors |
2 reviews | 9.0 / 10 |
Esbriet
Generic name: pirfenidone Drug class: miscellaneous uncategorized agents |
8 reviews | 7.9 / 10 |
Evrysdi
Generic name: risdiplam Drug class: miscellaneous uncategorized agents |
||
Fuzeon
Generic name: enfuvirtide Drug class: miscellaneous antivirals |
5 reviews | 9.4 / 10 |
Gavreto
Generic name: pralsetinib Drug class: multikinase inhibitors |
||
Gazyva
Generic name: obinutuzumab Drug class: CD20 monoclonal antibodies |
||
Hemlibra
Generic name: emicizumab Drug class: miscellaneous coagulation modifiers |
2 reviews | 10 / 10 |
Herceptin
Generic name: trastuzumab Drug class: HER2 inhibitors |
9 reviews | 8.9 / 10 |
Herceptin Hylecta
Generic name: hyaluronidase/trastuzumab Drug class: HER2 inhibitors |
1 review | 10 / 10 |
Kadcyla
Generic name: ado-trastuzumab emtansine Drug class: HER2 inhibitors |
||
Lucentis
Generic name: ranibizumab Drug class: anti-angiogenic ophthalmic agents |
13 reviews | 6.5 / 10 |
Lunsumio
Generic name: mosunetuzumab Drug class: miscellaneous antineoplastics |
1 review | 8.0 / 10 |
Nutropin AQ
Generic name: somatropin Drug class: growth hormones |
||
Ocrevus
Generic name: ocrelizumab Drug class: CD20 monoclonal antibodies |
153 reviews | 5.0 / 10 |
Pegasys
Generic name: peginterferon alfa-2a Drug class: antiviral interferons |
12 reviews | 6.5 / 10 |
Perjeta
Generic name: pertuzumab Drug class: HER2 inhibitors |
||
Phesgo
Generic name: hyaluronidase/pertuzumab/trastuzumab Drug class: HER2 inhibitors |
||
PiaSky
Generic name: crovalimab |
||
Polivy
Generic name: polatuzumab vedotin Drug class: miscellaneous antineoplastics |
||
Pulmozyme
Generic name: dornase alfa Drug class: miscellaneous respiratory agents |
1 review | 10 / 10 |
Rituxan
Generic name: rituximab Drug class: antirheumatics, CD20 monoclonal antibodies |
45 reviews | 8.2 / 10 |
Rituxan Hycela
Generic name: hyaluronidase/rituximab Drug class: CD20 monoclonal antibodies |
||
Rozlytrek
Generic name: entrectinib Drug class: multikinase inhibitors |
||
Susvimo
Generic name: ranibizumab Drug class: anti-angiogenic ophthalmic agents |
||
Tamiflu
Generic name: oseltamivir Drug class: neuraminidase inhibitors |
520 reviews | 6.0 / 10 |
Tecentriq
Generic name: atezolizumab Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) |
||
TNKase
Generic name: tenecteplase Drug class: thrombolytics |
||
Vabysmo
Generic name: faricimab Drug class: anti-angiogenic ophthalmic agents |
18 reviews | 8.7 / 10 |
Valcyte
Generic name: valganciclovir Drug class: purine nucleosides |
2 reviews | 5.0 / 10 |
Valium
Generic name: diazepam Drug class: benzodiazepine anticonvulsants, benzodiazepines |
314 reviews | 8.7 / 10 |
Venclexta
Generic name: venetoclax Drug class: miscellaneous antineoplastics |
6 reviews | 8.2 / 10 |
Xeloda
Generic name: capecitabine Drug class: antimetabolites |
28 reviews | 6.6 / 10 |
Xofluza
Generic name: baloxavir marboxil Drug class: miscellaneous antivirals |
26 reviews | 7.7 / 10 |
Xolair
Generic name: omalizumab Drug class: selective immunosuppressants |
199 reviews | 7.6 / 10 |
Zelboraf
Generic name: vemurafenib Drug class: multikinase inhibitors |
4 reviews | 6.2 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
Discontinued Drugs
Brand/Generic Name | Reviews | Rating |
---|---|---|
Tarceva
Generic name: erlotinib Drug class: EGFR inhibitors |
35 reviews | 8.4 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |